Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
Christopher R CogleBradley CollinsDaniel TurnerLeslie C PettifordRaphael BosséKimberly E HawkinsZackary BeachampElizabeth WiseChristina ClineWilliam S MayJan S MorebJack HsuJohn HiemenzRandall BrownMaxim NorkinJohn R WingardFatih UckunPublished in: British journal of haematology (2020)